期刊文献+

补充钙剂对绝经后妇女骨质疏松的预防作用 被引量:14

Calcium Supplementation and Postmenopausal Osteoporosis.
原文传递
导出
摘要 目的探讨补充钙剂对预防绝经后妇女骨质疏松的有效性和安全性。方法用回顾性分析法分析1992年12月至2007年9月文献关于补充钙剂及钙剂联合其他药物应用对绝经后妇女骨质疏松预防的高质量研究报道,分析其所用方法、质量和效果。结果单纯补充钙剂对预防45~70岁白色及黄色人种妇女的骨质疏松有效,但钙剂联合雌激素和(或)孕激素、维生素D3、降钙素等较单用钙剂对预防骨质疏松效果更好。每日摄入800 mg钙剂,并不影响人体对锌或铁的吸收,也不会导致高尿钙症;而不同时间补充钙剂,可能会影响胃、肠对钙及草酸盐的吸收,从而增加肾结石发生风险;合理饮食、均衡蛋白质及盐类摄入,可有效预防骨密度降低;绝经后妇女应尽早开始多摄入富含钙食物,并根据年龄、胃酸分泌是否不足及对钙剂的个体反应,选用恰当钙剂。结论补充钙剂可预防绝经后妇女骨密度降低及钙丢失,防止骨质疏松的发生。口服钙剂应在餐后1.0 h^1.5 h。理想的钙剂应为含钙量高、体内易溶解、接近中性、安全无毒、生物利用度高、价廉,建议使用碳酸钙。 Objective To discuss the effectiveness of calcium supplements for the prevention of osteoporosis in postmenopausal women. Methods The lectures of calcium supplementation for the prevention of osteoporosis in 45 to 70-year-old women from December 1992 to September 2007 were included and analyzed retrospectively. Results Calcium could prevent the osteoporosis, on the other hand, the effectiveness of supplementation of calcium plus estrogen and (or) progesterone, vitamin D3, caleitonin are much better than using calcium only. Calcium intake(800 mg/d) will not reduce the absorption of zinc or ferrum, not break the balance in body, and will not result in hypercalcinemia. Variation in the time of calcium supplement may affect gastrointestinal absorption of both calcium and oxalate and may associate with variable risk of calcium oxalate nephrolithiasis. Postmenopausal women should take in high-calcium food as early as possible, choose proper calcium supplements according to their age. The content of hydrochloric acid in gastric juice and the reaction of different calcium supplements. Conclusion Calcium supplements, rational diet, balanced intake of protein and salt can prevent the loss of bone mineral density. Bone mineral content could reduce the risk of osteoporosis in postmenopausal women. It is better for them to take the oral calcium supplements between one to one and half an hour after meal. The ideal calcium supplements should be rich in calcium, safe, nonpoisonous, approaching neutrality, easy to be absorbed and proper price. Moreover, calcium carbonate is recommended.
出处 《中华妇幼临床医学杂志(电子版)》 CAS 2009年第1期37-41,共5页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
关键词 围绝经期 骨质疏松 预防 calcium peri-menopause osteoporosis prevention
  • 相关文献

参考文献10

  • 1许良智,庄静,乔林.绝经后骨质疏松性骨折的危险因素及预防[J].实用妇产科杂志,2006,22(7):391-393. 被引量:9
  • 2周晔,周姝.围绝经期及绝经5年内和大于5年妇女对雌激素替代治疗的反应:腰椎及髋部骨密度变化[J].中国临床康复,2005,9(19):168-169. 被引量:1
  • 3谭世桥,唐晓红.钙剂在绝经后骨质疏松症防治中的作用[J].中国临床康复,2004,8(3):541-541. 被引量:12
  • 4杨式之,赵霞.更年期妇女性激素与失骨关系的探讨[J]华西医科大学学报,1988(02).
  • 5Gayatri Gupta,Wilbert S. Aronow. Treatment of Postmenopausal Osteoporosis[J] 2007,Comprehensive Therapy(3):114~119
  • 6Sarah L. Morgan,Debbie C. Strong,Elizabeth M. Kitchin,Kelley E. Johnston,Robert A. DiSilvestro,Tsunenobu Tamura. Zinc status of women with low bone mineral density who receive calcium supplements[J] 2006,Biological Trace Element Research(3):211~222
  • 7Anne M. Kenny,Karen M. Prestwood,Bradley Biskup,Bertha Robbins,Enid Zayas,Alison Kleppinger,Joseph A. Burleson,Lawrence G. Raisz. Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women[J] 2004,Osteoporosis International(4):290~294
  • 8S. Domrongkitchaiporn,B. Ongphiphadhanakul,W. Stitchantrakul,N. Piaseu,S. Chansirikarn,G. Puavilai,R. Rajatanavin. Risk of Calcium Oxalate Nephrolithiasis after Calcium or Combined Calcium and Calcitriol Supplementation in Postmenopausal Women[J] 2000,Osteoporosis International(6):486~492
  • 9A. Gürlek,M. Bayraktar,O. Gedik. Comparison of Calcitriol Treatment with Etidronate–Calcitriol and Calcitonin–Calcitriol Combinations in Turkish Women with Postmenopausal Osteoporosis: A Prospective Study[J] 1997,Calcified Tissue International(1):39~43
  • 10H. Rico,M. Revilla,E. R. Hernández,L. F. Villa,M. Alvarez Buergo. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: A prospective study[J] 1995,Calcified Tissue International(3):181~185

二级参考文献11

  • 1张俊,葛宁,黄晓丽,张新军.骨质疏松症的药物治疗评价[J].中国实用内科杂志:临床前沿版,2006,26(2):313-315. 被引量:25
  • 2扬式之 赵霞.更年期妇女性激素与失骨关系的探讨 [J].华西医科大学学报,1988,19(2):193-5.
  • 3Moore RA, Livial: a review of clinical studies. Br J Obstet Gynaecol 1999; 106 Suppl 19:1-21.
  • 4Volker W, Coelingh Bennink HJ, Helmond FA. Effects of tibolone on the endometrium. Climacteric 2001;4(3):203-8.
  • 5Conner P, Christow A, Kersemaekers W, et al. A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment. Climacteric 2004;7(1):50-8.
  • 6Gallagher JC, Baylink DJ,Freeman R, et al. Prevention of loss with tibolone in post menopausal women: results of two randomized, double-blind, placebo-controlled, doze-finding studies. J Clin Endocrinol Metab 2001;86:4717-26.
  • 7郝新平.我国骨质疏松症研究水平亟待提高.中国医学论坛报,2001,27(23):2-2.
  • 8Nieves,Jeri W.Osteoporosis:the role of micronutrients.American Journal of Clinical Nutrition.,2005,81(5):1232S ~ 1239S.
  • 9田华,葛勤,张恩娟,刘同华.钙制剂的质量评价及合理应用[J].中国药业,2003,12(7):21-23. 被引量:9
  • 10张丽萍.植物雌激素对绝经后骨质疏松的影响[J].中国临床康复,2003,7(18):2589-2589. 被引量:11

共引文献19

同被引文献148

引证文献14

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部